Chinese Ai-Based Drug Maker Xbiome Bags Nearly $100M In Series B Round

Dec 22, 2021•over 3 years ago

Amount Raised

$100 Million

Round Type

series b

Description

Xbiome, a Chinese drug development platform that utilises AI, has pocketed nearly $100 million in a Series B round

Company Information

Company

Xbiome

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech